Cancer of unknown primary site: Review of consecutive cases at the National Cancer Center Hospital of Japan

International Journal of Clinical Oncology

Volumn 11, Issue 6, 2006, Pages 421-425

  Yakushiji, Satomi ^a   Ando, Masashi ^a   Yonemori, Kan ^a   Kohno, Tsutomu ^a   Shimizu, Chikako ^a   Katsumata, Noriyuki ^a   Fujiwara, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cancer of unknown primary; Consecutive cases; Empirical chemotherapy; Platinum containing regimen; Taxanes

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADENOCARCINOMA; ADULT; AGED; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CERVICAL LYMPH NODE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; LYMPHATIC SYSTEM TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE CYCLE TREATMENT; PATIENT REFERRAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANCER CARE FACILITIES; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33845799205     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0599-9     Document Type: Review

References (27)

1. FA Greco JD Hainsworth 2005 Cancer of unknown primary site VT Devia Jr S Hellman SA Rosenberg Principles and practice of oncology, sixth edn Lippincott-Raven Philadelphia 2213 2236
2. F Levi VC Te G Erler 2002 Epidemiology of unknown primary tumors Eur J Cancer 38 1810 1812
3. AJ van de Wouw MLG Janssen-Heijnen Coebergh 2002 Epidemiology of unknown primary tumors; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992 Eur J Cancer 38 409 413
4. JS Nystrom JM Weiner RM Wolf 1979 Identifying the primary site in metastatic cancer of unknown origin: inadequacy of roentgenographic procedures JAMA 241 381 383
5. RJ Steckel AR Kagan 1980 Diagnostic persistence in working up metastatic cancer with an unknown primary site Radiology 134 367 369
6. JL Abbruzzese MC Abbruzzese KR Hess 1994 Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients J Clin Oncol 12 1272 1280
7. S Culine A Kramar M Saghatchian 2002 Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site J Clin Oncol 20 4679 4683
8. RH Jesse CA Perez GH Fletcher 1973 Cervical lymph node metastases: unknown primary cancer Cancer 31 854 859
9. J Patel T Nemoto D Rosner 1981 Axillary lymph node metastases from an occult breast cancer Cancer 47 2923 2927
10. CM Strnad WW Grosh J Baxter 1989 Peritoneal carcinomatosis of unknown primary site in women Ann Intern Med 111 213 217
11. JD Hainsworth DH Johnson FA Greco 1988 Poorly differentiated neuroendocrine cancer of unknown primary site: a newly recognized clinicopathologic entity Ann Intern Med 109 364 371
12. RL Richardson RA Shoumacher MF Fer 1981 The unrecognized extragonadal germ cell cancer syndrome Ann Intern Med 94 181 186
13. R Bugat A Bataillard T Lesimple 2003 Practice guideline. Summary of the standards, options and recommendations for the management of patients with carcinoma of unknown primary site (2002) Br J Cancer 89 Suppl 1 s59 s66
14. H Mukai T Watanabe M Ando 2003 Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel Int J Clin Oncol 8 23 25
15. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481
16. MN Raber J Faintuch LJ Abbruzzese 1991 Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic cancer of unknown primary origin Ann Oncol 2 519 520
17. CI Falkson GL Cohen 1998 Mitomycin, epirubicin and cisplatin versus mitomycin-C alone as therapy for cancer of unknown primary origin Oncology 55 116 121
18. E Warner R Goel J Chang 1998 A multicenter phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS) Br J Cancer 77 2376 2380
19. FA Greco JB Erland LH Morrissey 2000 Cancer of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin Ann Oncol 11 211 215
20. FA Greco HA Burris 3rd EB Erland 2000 Cancer of unknown primary site. Long term follow-up after treatment with paclitaxel, carboplatin and etoposide Cancer 89 2655 2660
21. E Briasoulis H Kalofonos D Bafaloukos 2000 Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II study. The Hellenic Cooperative Oncology Group Study J Clin Oncol 18 3101 3117
22. E Voog Y Merrouche V Trillet-Lenoir 2000 Multicentric phase II study of cisplatin and etoposide in patients with metastatic cancer of unknown primary Am J Clin Oncol 23 614 616
23. JE Dowell AM Garrett Y Shyr 2001 A randomized phase II trial in patients with cancer of unknown primary site Cancer 91 592 597
24. FA Greco HA Burris 3rd S Litchy 2002 Gemcitabine, carboplatin and paclitaxel for patients with cancer of unknown primary site: a Minnie Pearl Cancer Research Network study J Clin Oncol 20 1651 1656
25. S Culine A Lortholary JJ Voigt 2003 Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study - trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01) J Clin Oncol 21 3479 3482
26. G Bloom IV Yang D Boulware 2004 Multi-platform, multi-site, microarray-based human tumor classification Am J Pathol 97 9 16
27. N Pavlidis E Briasoulis J Hainsworth 2003 Diagnostic and therapeutic management of cancer of an unknown primary Eur J Cancer 39 1990 2005